Lung Cancer and Chronic Obstructive Pulmonary Disease: Understanding the Complexity of Carcinogenesis

Overview

Journal Transl Lung Cancer Res

Date 2018 Nov 6

PMID 30393605

Citations 3

Authors

Cecilia Mouronte-Roibas

Alberto Ruano-Ravina

Alberto Fernandez-Villar

Affiliations

Soon will be listed here.

Citing Articles

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.

Ma A, Wang G, Du Y, Guo W, Guo J, Hu Y Front Oncol. 2022; 12:902955.

PMID: 36237340 PMC: 9552820. DOI: 10.3389/fonc.2022.902955.

Transcriptomic data exploration of consensus genes and molecular mechanisms between chronic obstructive pulmonary disease and lung adenocarcinoma.

Zhang S, Pang K, Feng X, Zeng Y Sci Rep. 2022; 12(1):13214.

PMID: 35918384 PMC: 9345949. DOI: 10.1038/s41598-022-17552-x.

Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease.

Zhang L, Chen J, Yang H, Pan C, Li H, Luo Y J Cancer. 2021; 12(4):996-1010.

PMID: 33442399 PMC: 7797649. DOI: 10.7150/jca.51264.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Leiro-Fernandez V, Mouronte-Roibas C, Ramos-Hernandez C, Botana-Rial M, Gonzalez-Pineiro A, Garcia-Rodriguez E . Changes in clinical presentation and staging of lung cancer over two decades. Arch Bronconeumol. 2014; 50(10):417-21. DOI: 10.1016/j.arbres.2014.03.003. View

Sandri B, Kaplan A, Hodgson S, Peterson M, Avdulov S, Higgins L . Multi-omic molecular profiling of lung cancer in COPD. Eur Respir J. 2018; 52(1). PMC: 6618293. DOI: 10.1183/13993003.02665-2017. View

Smith B, Schwartzman K, Kovacina B, Taylor J, Kasymjanova G, Brandao G . Lung cancer histologies associated with emphysema on computed tomography. Lung Cancer. 2011; 76(1):61-6. DOI: 10.1016/j.lungcan.2011.09.003. View

Bauer C, Diesinger I, Brass N, Steinhart H, Iro H, Meese E . Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma. Cancer. 2001; 92(4):822-9. DOI: 10.1002/1097-0142(20010815)92:4<822::aid-cncr1388>3.0.co;2-a. View

Durham A, Adcock I . The relationship between COPD and lung cancer. Lung Cancer. 2015; 90(2):121-7. PMC: 4718929. DOI: 10.1016/j.lungcan.2015.08.017. View

Fujii T, Dracheva T, Player A, Chacko S, Clifford R, Strausberg R . A preliminary transcriptome map of non-small cell lung cancer. Cancer Res. 2002; 62(12):3340-6. View

Barreiro E, Fermoselle C, Mateu-Jimenez M, Sanchez-Font A, Pijuan L, Gea J . Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD. Free Radic Biol Med. 2013; 65:859-871. DOI: 10.1016/j.freeradbiomed.2013.08.006. View

Pastor M, Nogal A, Molina-Pinelo S, Melendez R, Salinas A, Gonzalez De la Pena M . Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics. 2013; 89:227-37. DOI: 10.1016/j.jprot.2013.04.037. View

10.

Young R, Hopkins R, Christmas T, Black P, Metcalf P, Gamble G . COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009; 34(2):380-6. DOI: 10.1183/09031936.00144208. View

11.

Spaw M, Anant S, Thomas S . Stromal contributions to the carcinogenic process. Mol Carcinog. 2016; 56(4):1199-1213. PMC: 5354948. DOI: 10.1002/mc.22583. View

12.

Villar Alvarez F, Muguruza Trueba I, Belda Sanchis J, Molins Lopez-Rodo L, Rodriguez Suarez P, Sanchez de Cos Escuin J . Recommendations of the Spanish Society of Pneumology and Thoracic Surgery on the diagnosis and treatment of non-small-cell lung cancer. Arch Bronconeumol. 2016; 52 Suppl 1:2-62. DOI: 10.1016/S0300-2896(16)30198-3. View

13.

Ruano-Ravina A, Pereyra M, Castro M, Perez-Rios M, Abal-Arca J, Barros-Dios J . Genetic susceptibility, residential radon, and lung cancer in a radon prone area. J Thorac Oncol. 2014; 9(8):1073-80. DOI: 10.1097/JTO.0000000000000205. View

14.

Mouronte-Roibas C, Leiro-Fernandez V, Fernandez-Villar A, Botana-Rial M, Ramos-Hernandez C, Ruano-Ravina A . COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016; 382(2):240-244. DOI: 10.1016/j.canlet.2016.09.002. View

15.

Ofiara L, Navasakulpong A, Beaudoin S, Gonzalez A . Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer. Front Oncol. 2014; 4:253. PMC: 4170137. DOI: 10.3389/fonc.2014.00253. View

16.

Miravitlles M, Soler-Cataluna J, Calle M, Molina J, Almagro P, Quintano J . Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. Arch Bronconeumol. 2017; 53(6):324-335. DOI: 10.1016/j.arbres.2017.03.018. View

17.

Mouronte-Roibas C, Leiro-Fernandez V, Ruano-Ravina A, Ramos-Hernandez C, Abal-Arca J, Parente-Lamelas I . Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization. Respiration. 2018; 95(6):414-421. DOI: 10.1159/000487243. View

18.

Abal Arca J, Parente Lamelas I, Almazan Ortega R, Blanco Perez J, Toubes Navarro M, Marcos Velazquez P . [Lung cancer and COPD: a common combination]. Arch Bronconeumol. 2009; 45(10):502-7. DOI: 10.1016/j.arbres.2009.07.005. View

19.

Wasswa-Kintu S, Gan W, Man S, Pare P, Sin D . Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005; 60(7):570-5. PMC: 1747470. DOI: 10.1136/thx.2004.037135. View

20.

Wauters E, Janssens W, Vansteenkiste J, Decaluwe H, Heulens N, Thienpont B . DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature. Thorax. 2015; 70(12):1113-22. DOI: 10.1136/thoraxjnl-2015-207288. View